These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

617 related articles for article (PubMed ID: 12415253)

  • 1. Vascular and haematopoietic stem cells: novel targets for anti-angiogenesis therapy?
    Rafii S; Lyden D; Benezra R; Hattori K; Heissig B
    Nat Rev Cancer; 2002 Nov; 2(11):826-35. PubMed ID: 12415253
    [No Abstract]   [Full Text] [Related]  

  • 2. Regulators of angiogenesis as targets for anti-angiogenic tumor therapy.
    Breier G; Heidenreich R; Gaumann A; Groot M; Licht A; Nicolaus A; Schmitz J; Reichmann E; Plate KH; Vajkoczy P
    Ann Hematol; 2002; 81 Suppl 2():S71-2. PubMed ID: 12611084
    [No Abstract]   [Full Text] [Related]  

  • 3. The Id proteins and angiogenesis.
    Benezra R; Rafii S; Lyden D
    Oncogene; 2001 Dec; 20(58):8334-41. PubMed ID: 11840326
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Molecular mechanisms of vasculogenesis and angiogenesis. What regulates vascular growth?].
    Joussen AM; Kirchhof B; Gottstein C
    Ophthalmologe; 2003 Apr; 100(4):284-91. PubMed ID: 12682760
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Use of tumor-activated hepatic stellate cell as a target for the preclinical testing of anti-angiogenic drugs against hepatic tumor development.
    Olaso E; Vidal-Vanaclocha F
    Methods Mol Med; 2003; 85():79-86. PubMed ID: 12710199
    [No Abstract]   [Full Text] [Related]  

  • 6. Vascular endothelial growth factor as a target for antiangiogenic therapy.
    Gordon MS
    J Clin Oncol; 2000 Nov; 18(21 Suppl):45S-6S. PubMed ID: 11060326
    [No Abstract]   [Full Text] [Related]  

  • 7. In vitro and in vivo angiogenesis in PC12 pheochromocytoma cells is mediated by vascular endothelial growth factor.
    Middeke M; Hoffmann S; Hassan I; Wunderlich A; Hofbauer LC; Zielke A
    Exp Clin Endocrinol Diabetes; 2002 Nov; 110(8):386-92. PubMed ID: 12518248
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Vascular endothelial growth factor and anti-angiogenic peptides as therapeutic and investigational molecules.
    Zachary I
    IDrugs; 2003 Mar; 6(3):224-31. PubMed ID: 12789611
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The clinical implications of angiogenesis in the treatment of cancer.
    Aoun E; Taher A
    J Med Liban; 2002; 50(1-2):32-8. PubMed ID: 12841311
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Angiogenesis in hematologic malignancies.
    Mesters RM
    Ann Hematol; 2002; 81 Suppl 2():S72-4. PubMed ID: 12611085
    [No Abstract]   [Full Text] [Related]  

  • 11. [Tumor angiogenesis].
    Bussolino F
    Recenti Prog Med; 1999 Jan; 90(1):28-36. PubMed ID: 10193163
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Anti-VEGF antibody in experimental hepatoblastoma: suppression of tumor growth and altered angiogenesis.
    McCrudden KW; Hopkins B; Frischer J; Novikov A; Huang J; Kadenhe A; New T; Yokoi A; Yamashiro DJ; Kandel JJ; Middlesworth W
    J Pediatr Surg; 2003 Mar; 38(3):308-14; discussion 308-14. PubMed ID: 12632340
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The bloody fate of endothelial stem cells.
    Kubo H; Alitalo K
    Genes Dev; 2003 Feb; 17(3):322-9. PubMed ID: 12569121
    [No Abstract]   [Full Text] [Related]  

  • 14. Mechanism of thrombin-induced angiogenesis.
    Maragoudakis ME; Tsopanoglou NE; Andriopoulou P
    Biochem Soc Trans; 2002 Apr; 30(2):173-7. PubMed ID: 12023846
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Can mosaic tumor vessels facilitate molecular diagnosis of cancer?
    Folkman J
    Proc Natl Acad Sci U S A; 2001 Jan; 98(2):398-400. PubMed ID: 11209044
    [No Abstract]   [Full Text] [Related]  

  • 16. A targeted approach for antiangiogenic therapy of metastatic human colon cancer.
    Ellis LM
    Am Surg; 2003 Jan; 69(1):3-10. PubMed ID: 12575772
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Neoplasms and angiogenesis].
    Lewy-Trenda I
    Pol Merkur Lekarski; 2002 Sep; 13(75):225-8. PubMed ID: 12474576
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Blockade of EphA receptor tyrosine kinase activation inhibits vascular endothelial cell growth factor-induced angiogenesis.
    Cheng N; Brantley DM; Liu H; Lin Q; Enriquez M; Gale N; Yancopoulos G; Cerretti DP; Daniel TO; Chen J
    Mol Cancer Res; 2002 Nov; 1(1):2-11. PubMed ID: 12496364
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Significance of vascular endothelial growth factor--VEGF--in tumor angiogenesis. Therapeutic possibilities in solid tumors].
    Werther K; Nielsen HJ
    Ugeskr Laeger; 2000 Sep; 162(37):4916-20. PubMed ID: 11002739
    [No Abstract]   [Full Text] [Related]  

  • 20. Endothelial survival factors as targets for antineoplastic therapy.
    Reinmuth N; Stoeltzing O; Liu W; Ahmad SA; Jung YD; Fan F; Parikh A; Ellis LM
    Cancer J; 2001; 7 Suppl 3():S109-19. PubMed ID: 11779081
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 31.